FDA Releases Draft Guidance on Communication with IND Sponsors During Drug Development

Summary

The FDA has published a draft guidance outlining best practices for communication between IND sponsors and FDA during drug development, aiming to improve transparency and efficiency in the process, ultimately leading to faster availability of safe and effective drugs to the public.